Stent And NotMary E. Russell

List of bibliographic references

Number of relevant bibliographic references: 11.

Ident.	Authors (with country if any)	Title
000134	Melissa Sgarioto [Australie, France] ; Raju Adhikari [Australie] ; Pathiraja A. Gunatillake [Australie] ; Tim Moore [Australie] ; François Malherbe [Australie] ; Marie-Danielle Nagel [France] ; John Patterson [Australie]	Properties and in vitro evaluation of high modulus biodegradable polyurethanes for applications in cardiovascular stents
000D27	Feroze Nazneen [Irlande (pays)] ; Gregoire Herzog [France] ; Damien W. M. Arrigan [Australie] ; Noel Caplice [Irlande (pays)] ; Pasquale Benvenuto [Canada] ; Paul Galvin [Irlande (pays)] ; Michael Thompson [Canada]	Surface chemical and physical modification in stent technology for the treatment of coronary artery disease
001805	Giuseppe Ferrante [Italie] ; Patrizia Presbitero [Italie] ; Marco Valgimigli [Italie] ; Marie-Claude Morice [France] ; Paolo Pagnotta [Italie] ; Guido Belli [Italie] ; Elena Corrada [Italie] ; Yoshinobu Onuma [Pays-Bas] ; Peter Barlis [Australie] ; Didier Locca [Suisse] ; Eric Eeckhout [Suisse] ; Carlo Di Mario [Royaume-Uni] ; Patrick W. Serruys [Pays-Bas]	Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials
001E91	Kurt Huber [Autriche] ; David R. Jr Holmes [États-Unis] ; Arnoud W. Van T Hof [Pays-Bas] ; Gilles Montalescot [France] ; Philip E. Aylward [Australie] ; G. Amadeo Betriu [Espagne] ; Petr Widimsky [République tchèque] ; Cynthia M. Westerhout [Canada] ; Christopher B. Granger [États-Unis] ; Paul W. Armstrong [Canada]	Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial
002363	Harvey D. White [Nouvelle-Zélande] ; Philip E. Aylward [Australie] ; Richard Gallo [Canada] ; Christoph Bode [Allemagne] ; Gabriel Steg [France] ; Steven R. Steinhubl [États-Unis] ; Gilles Montalescot [France]	Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
003A94	Didier Blanchard [France] ; Gian Battista Danzi [Italie] ; Philip Urban [Suisse] ; Morris Moseri [Israël] ; Craig Juergens [Australie] ; Philip Guyon [France] ; Bernd Nowak [Allemagne] ; Damras Tresucosol [Thaïlande] ; Maarten J. Suttorp [Pays-Bas] ; Ahmad Farshid [Australie] ; Ran Kornowski [Israël] ; Eulogio Garcia [Espagne] ; Richard Yeend [Australie] ; Hirofumi Nagai [Japon] ; Dragica Paunovic [Belgique]	A novel ultra-thin bare metal stent (BMS) : results from a worldwide registry
004071	Gilles Montalescot [France] ; Harvey D. White [Nouvelle-Zélande] ; Richard Gallo [Canada] ; Marc Cohen [États-Unis] ; P. Gabriel Steg [France] ; Philip E. G. Aylward [Australie] ; Christoph Bode [Allemagne] ; Massimo Chiariello [Italie] ; Spencer B. Iii King [États-Unis] ; Robert A. Harrington [États-Unis] ; Walter J. Desmet [Belgique] ; Carlos Macaya [Espagne] ; Steven R. Steinhubl [États-Unis]	Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
004C87	Patrick W. Serruys [Pays-Bas] ; John A. Ormiston [Australie] ; Georgios Sianos [Pays-Bas] ; Eduardo Sousa [Brésil] ; Eberhard Grube [Allemagne] ; Peter Den Heijer [Pays-Bas] ; Pim De Feyter [Pays-Bas] ; Pawel Buszman [Pologne] ; Albert Schömig [Allemagne] ; Jean Marco [France] ; Lech Polonski [Pologne] ; Leif Thuesen [Danemark] ; Andreas M. Zeiher [Allemagne] ; J. H. Nicholas Bett [Australie] ; Maarten J. Suttorp [Pays-Bas] ; Helmut D. Glogar [Autriche] ; Mark Pitney [Australie] ; Gerard T. Wilkins [Nouvelle-Zélande] ; Robert Whitbourn [Belgique] ; Susan Veldhof [Australie] ; Karine Miquel [Australie] ; Rachel Johnson [Australie] ; Leslie Coleman [Australie] ; Renu Virmani [États-Unis]	Actinomycin-eluting stent for coronary revascularization. A randomized feasibility and safety study: The ACTION Trial
004D97	Gilles Montalescot [France] ; Frans Van De Werf [Belgique] ; Dietrich C. Gulba [Allemagne] ; Alvaro Avezum [Brésil] ; David Brieger [Australie] ; Brian M. Kennelly [États-Unis] ; Tomasz Mazurek [Pologne] ; Frederick Spencer [États-Unis] ; Kami White [États-Unis] ; Joel M. Gore [États-Unis]	Stenting and glycoprotein IIb/IIIa inhibition in patients with Acute myocardial infarction undergoing percutaneous Coronary intervention: Findings from the Global Registry of Acute Coronary Events (GRACE)
005613	Alexander Jr Black [Australie] ; Rosario Cortina [France] ; Irene Bossi [France] ; Rémi Choussat [France] ; Jean Fajadet [Australie] ; Jean Marco [France]	Unprotected left main Coronary artery stenting: Correlates of midterm survival and impact of patient selection
005825	D. Favier [France] ; L. Orgeas [France] ; D. Ferrier [France] ; P. Poncin [France] ; Y. Liu [Australie]	Influence of manufacturing methods on the homogeneity and properties of nitinol tubular stents

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024